First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma
First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma
Case Western Reserve University School of Medicine, Cleveland, OH
Targeting Beta-Catenin Mediated Activity in Metastatic Osteosarcoma
Targeting Beta-Catenin Mediated Activity in Metastatic Osteosarcoma
Baylor College of Medicine, Houston, TX